12 insiders reported 13 Form 4 transactions for Poseida Therapeutics, Inc. (PSTX) over the past 18 months (most recent 2025-01-10). Recent activity: Malin Life Sciences Holdings Ltd (Insider) Sell 11.8M shares, LEONHARDT HARRY J (GC & Chief Compliance Officer) Sell 223,640 shares, Lloyd Marcea Bland (Director) Sell 68,950 shares, BAUM CHARLES M (Director) Sell 78,600 shares, Amado Rafael (Director) Sell 58,950 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-10 | Malin Life Sciences Holdings Ltd | Insider | Sell | 11.8M | $0 |
| 2025-01-08 | LEONHARDT HARRY J | GC & Chief Compliance Officer | Sell | 223,640 | $0 |
| 2025-01-08 | Lloyd Marcea Bland | Director | Sell | 68,950 | $0 |
| 2025-01-08 | BAUM CHARLES M | Director | Sell | 78,600 | $0 |
| 2025-01-08 | Amado Rafael | Director | Sell | 58,950 | $0 |
| 2025-01-08 | Gergen Mark J | President and CEO | Sell | 636,726 | $0 |
| 2025-01-08 | Schmid John P. | Director | Sell | 58,950 | $0 |
| 2025-01-08 | Collins Cynthia | Director | Sell | 58,950 | $0 |
| 2025-01-08 | Mylet Johanna | Chief Financial Officer | Sell | 254,852 | $0 |
| 2025-01-08 | Corning Luke | Director | Sell | 58,950 | $0 |
| 2025-01-08 | Yarema Kristin | President and CEO | Sell | 615,836 | $0 |
| 2025-01-08 | Rizvi Syed Ali-aamir | Chief Medical Officer | Sell | 185,000 | $0 |
| 2025-01-03 | Gergen Mark J | Executive Chairman | Sell | 23,313 | $223,805 |
Source: SEC Form 4 filings · as of 2025-01-10
